“…In a further step, these tumors can become invasive, which is marked by the disruption of the basement membrane and potential seeding of metastases (Gilbertson et al, 1983;Burstein et al, 2004;Simpson et al, 2005;Sorenmo et al, 2009). On a molecular level, many of the key alterations in human breast cancer are faithfully recapitulated in CMTs, including germline mutations in BRCA1, BRCA2, and TP53 that are associated with an enhanced risk of hereditary cancer in humans (Liu et al, 2014;Matos and Santos, 2015;Santos and Matos, 2015;Schiffman and Breen, 2015). And finally, besides clinical factors such as tumor size, lymph node involvement, and clinical stage, the prognostic value of histo-pathological aspects such as tumor type and grade, and molecular subtypes (luminal A, luminal B, HER2-enriched, and basal-like) is conserved between canine and human breast cancer (Rivera et al, 2009;Queiroga et al, 2011b;Sleeckx et al, 2011;Lahkhani et al, 2012;Rasotto et al, 2012Rasotto et al, , 2017Im et al, 2013;Pena et al, 2013;Nguyen et al, 2017).…”